Combined Inhibition of CDK4/6 and AKT is Highly Effective Against the Luminal Androgen Receptor (LAR) Subtype of Triple Negative Breast Cancer.
CANCER RESEARCH（2024）
关键词
CDK4/6 Inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH（2024）